While TLR2 signaling is impaired in the acute phase of AD, it has also been suggested that aberrant activation of TLR2 may play a role in the development of the Th1 immune pathway leading to the exacerbation and persistence of inflammation in the chronic phase of AD [53,54]. Here, TLR2 is linked to Alzheimer disease.